336 results
Page 4 of 17
6-K
EX-99.1
fi3xr 45czy4fy0q2i
7 Nov 14
Live Filing
12:00am
6-K
EX-99.1
a7a0otc9mgqd liujty
7 Nov 14
Late Stage Data to be Presented at ACAAI 2014
12:00am
6-K
EX-99.1
mal xal6p
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
EX-99.1
oaczrm0
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
70hbh48kfdd5pt
12 Sep 14
Teva Presents Gene Expression Analysis at Joint ACTRIMS-ECTRIMS Meeting Demonstrating COPAXONE® (glatiramer acetate injection) Has a Complex Profile
12:00am
6-K
EX-99.1
iombi3
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
EX-99.1
xh6x beop
4 Sep 14
Teva Announces Launch of Generic Baraclude® TABLETS,0.5MG and 1MG, In the United States
12:00am
6-K
EX-99.1
6646nst1io69cg97
3 Sep 14
Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
12:00am
6-K
EX-99.1
q3djzxp8ki7izd zw
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
fjf4hqi11p0a
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
pajsb 60d4yp
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am
6-K
EX-99.1
c8d3nsv0zn26tia
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
djtg066 eyc4zrr
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
trsuj1j
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
skpn 5dkel
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
4hs2hl3sgb976 m5qe
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
6-K
EX-99.1
kut96a
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
klrk4ucoe fo
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
6-K
EX-99.1
orjnm12aspkoyzxjunn
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
2z9a radc08ru
3 Jun 14
Live Filing
12:00am